Saratov JOURNAL of Medical and Scientific Research

Analysis of production of the decellularized scaffolds and their potential use in cardiovascular surgery

Year: 2015, volume 11 Issue: №4 Pages: 615-620
Heading: Genetics Article type: Review
Authors: Brumberg V.A., Lauk-Dubitsky S.E., Astrelina Т.А., Kobzeva I.V., Bushmanov A.Y., Samoilov A.S.
Organization: State Scientific Research Center n.a. A.I. Burnasyan — Federal Medical Biophysical Center of Federal Medical Biological Agency

Data on application of decellularized scaffolds and tissue-engineered vascular conduits in the field of cardiovascular surgery have been analyzed, and also techniques for their procurement have been studied. For finding, selection and synthesis resources of research data from the systems Pubmed, ScienceDirect were used. The preference was given to the most informative, comprehensive and contemporary publications.

1. Badylak SF, Freytes DO, Gilbert TW. Extracellular matrix as a biological scaffold material: Structure and function. Acta Biomater 2009; 5(1): 1-13
2. Moroni F, Mirabella T. Decellularized matrices for cardiovascular tissue engineering. Am J Stem Cells 2014; 3 (1): 1-20
3. McMurray JJ, Adamopoulos S, Anker SD. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; 33 (14): 1787-847
4. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics — 2013 update: a report from the American Heart Association. Circulation 2013; 127 (1): 6-245
5. Banner NR, Bonser RS, Clark AL, et al. UK guidelines for referral and assessment of adults for heart transplantation. Heart 2011; 97 (18): 1520-7
6. Mehra MR, Kobashigawa J, Starling R, etal. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates — 2006. J Heart Lung Transplant 2006 Sep; 25 (9): 1024-42
7. Vega JD, Moore J, Murray S, Chen JM, Johnson MR, Dyke DB. Heart transplantation in the United States, 1998-2007. Am J Transplant 2009; 9 (4): 932-41
8. Zimmermann WH, Melnychenko I, Eschenhagen T. Engineered heart tissue for regeneration of diseased hearts. Biomaterials 2004; 25 (9): 1639-47
9. Zimmermann WH, Melnychenko I, Wasmeier G, et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 2006; 12 (4): 452-8
10. Shimizu T, Yamato M, Kikuchi A, Okano T. Cell sheet engineering for myocardial tissue reconstruction. Biomaterials 2003; 24 (13): 2309-16
11. Radisic M, Deen W, Langer R, Vunjak-Novakovic G. Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. Am J Physiol Heart Circ Physiol 2005; 288 (3): H1278-89
12. Radisic M, Park H, Chen F, Salazar-Lazzaro JE, et al. Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. Tissue Eng 2006; 12 (8): 2077-91
13. Song JJ, Ott HC. Organ engineering based on decellularized matrix scaffolds. Trends Mol Med 2011; 17 (8): 424-32
14. Robinson KA, Li J, Mathison M, et al. Extracellular matrix scaffold for cardiac repair. Circulation 2005; 112(9): 1135-43
15. Ott HC, Matthiesen TS, Goh SK, et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 2008; 14 (2): 213-21
16. Brinkley DM, Gelfand EV. Valvular heart disease: classic teaching and emerging paradigms. Am J Med 2013; 126 (12): 1035-42
17. Bonow RO, Carabello BA, et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol2008;52(13):e1-142
18. Brown JM, O'Brien SM, Wu C, et al. Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. Thorac Cardiovasc Surg 2009; 137 (1): 82-90
19. Chikwe J, Filsoufi F, Carpentier AF. Prosthetic valve selection for middle-aged patients with aortic stenosis. Nat Rev Cardiol2010;7(12):711-9
20. Smedira NG, Blackstone EH, Roselli ЕЕ. Are allografts the biologic valve of choice for aortic valve replacement in nonelderly patients? Comparison of explantation for structural valve deterioration of allograft and pericardial prostheses. J Thorac Cardiovasc Surg 2006; 131 (3): 558-564
21. Rippel RA, Ghanbari H, Seifalian AM. Tissue-engineered heart valve: future of cardiac surgery. World J Surg 2012; 36 (7): 1581-91
22. Vesely I. Heart valve tissue engineering. Circ Res 2005; 97 (8): 743-55
23. Lam MT, Wu JC. Biomaterial applications in cardiovascular tissue repair and regeneration. Expert Rev Cardiovasc Ther 2012; 10(8): 1039-49. 24. Dainese L, Guarino A, Burba I, et al. Heart valve engineering: decellularized aortic homograft seeded with human cardiac stromal cells. J Heart Valve Dis 2012; 21 (1): 125-34
25. O'Brien MF, Goldstein S, Walsh S, et al. The Syner Graft valve: a new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation. Semin Thorac Cardiovasc Surg 1999; 11 (1): 194-200
26. Brown JW, Ruzmetov M, Eltayeb O, Rodefeld MD, Turrentine MW. Performance of Syner Graft decellularized pulmonary homograft in patients undergoing a Ross procedure. Ann Thorac Surg 2011; 91: 416-422; discussion 422-413
27. Konertz W, Angeli E, Tarusinov G, et al. Right ventricular outflow tract reconstruction with decellularized porcine xenografts in patients with congenital heart disease. J Heart Valve Dis 2011; 20 (3): 341 -7
28. Perri G, Polito A, Esposito C, et al. Early and late failure of tissue-engineered pulmonary valve conduits used for right ventricular outflow tract reconstruction in patients with congenital heart disease. Eur J Cardiothorac Surg 2012; 41 (6): 1320-5
29. Hall MJ, DeFrances CJ, Wlliams SN, Golosinskiy A, Schwartzman A. National Hospital Discharge Survey: 2007 summary. Natl Health Stat Report 2010; 26 (29): 1-20, 24
30. Salacinski HJ, Goldner S, Giudiceandrea A, et al. The mechanical behavior of vascular grafts: a review. J BiomaterAppI 2001; 15(3): 241-78
31. Liu SQ, Moore MM, Yap С Prevention of mechanical stretch-induced endothelial and smooth muscle cell injury in experimental vein grafts. J Biomech Eng 2000; 122 (1): 31-8
32. Zilla P, Bezuidenhout D, Human P. Prosthetic vascular grafts: wrong models, wrong questions and no healing. Biomaterials 2007; 28 (34): 5009-27
33. Bordenave L, Fernandez P, Remy-Zolghadri M, et al. In vitro endothelialized ePTFE prostheses: clinical update 20 years after the first realization. Clin Hemorheol Microcirc 2005; 33 (3): 227-34
34. Matsumura G, Isayama N, Matsuda S, et al. Long-term results of cell-free biodegradable scaffolds for in situ tissue engineering of pulmonary artery in a canine model. Biomaterials 2013; 34 (27): 6422-8
35. Poh M, Boyer M, Solan A, et al. Blood vessels engineered from human cells. Lancet 2005; 365 (9477): 2122-4
36. Kelm JM, Lorber V, Snedeker JG, et al. A novel concept for scaffold-free vessel tissue engineering: self-assembly of microtissue building blocks. J Biotechnol 2010; 148 (1): 46-55
37. Macbeth GA, Rubin JR, Mclntyre KE Jr, Goldstone J, Malone JM. The relevance of arterial wall microbiology to the treatment of prosthetic graft infections: graft infection vs. arterial infection. J Vase Surg 1984; 1 (6): 750-6. 38. Lalka SG, Oelker LM., Malone JM, et al. Acellular vascular matrix: a natural endothelial cell substrate. Ann Vase Surg 1989; 3(2): 108-17
39. Fitzpatrick JC, Clark PM, Capaldi FM. Effect of decellularization protocol on the mechanical behavior of porcine descending aorta.Int J Biomater 2010
40. Zou Y, Zhang Y Mechanical evaluation of decellularized porcine thoracic aorta. J Surg Res 2012; 175 (2): 359-68
41. Martin ND, Schaner PJ, Tulenko TN, et al. In vivo behavior of decellularized vein allograft. J Surg Res 2005; 129 (1): 17-23
42. L'Heureux N, Paquet S, Labbe R, Germain L, Auger FA. A completely biological tissue-engineered human blood vessel. FASEB J 1998; 12 (1): 47-56
43. Hoenicka M, Schrammel S, Bursa J, et al. Development ofendothelium-denuded human umbilical veins as living scaffolds for tissue-engineered small-calibre vascular grafts. J Tissue Eng Regen Med 2013; 7 (4): 324-36
44. Bertanha M, Moroz A, Jaldin RG, et al. Morphofunctional characterization of decellularized vena cava as tissue engineering scaffolds. Exp Cell Res 2014
45. Syedain ZH, Lahti MT, Johnson SL, Tranquillo RT Implantation of completely biological engineered grafts following decellularization into the sheep femoral artery. Tissue Eng Part A 2014; 20 (11-12): 1726-34
46. Shin'oka T, Matsumura G, Hibino N, et al. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 2005; 129(6): 1330-8
47. Teebken OE, Puschmann C, Rohde B, et al. Human iliac vein replacement with a tissue-engineered graft. Vasa 2009; 38: 60-65
48. McAllister, Maruszewski M, Garrido SA, et al. Effectiveness of haemodialysis access withan autologous tissueengineered vascular graft: a multicentre cohortstudy. Lancet 2009; 373 (9673): 1440-6.

2015_04-01_615-620.pdf333.47 KB

No votes yet